Novo Nordisk NVO shares have lost 5% in the past three months, which translates to approximately $29 billion in market value, ...

Swiftly achieving glycemic control after a diagnosis of gestational diabetes can bring the baby's risk of obesity in ...

Eli Lilly surged 58% in 2024, driven by weight-loss drugs and strong earnings. The technical chart shows consolidation. See ...

Fried foods, such as French fries, fried chicken, and doughnuts, are typically high in unhealthy trans fats and saturated ...

With a market capitalization of over $800 billion, Eli Lilly (NYSE: LLY) is the largest pharmaceutical company in the world.

Semaglutide and tirzepatide treatment lead to significant weight loss and improve blood sugar control in individuals with ...

Swiftly achieving glycaemic control after a diagnosis of gestational diabetes can bring the baby’s risk obesity in childhood ...

WASHINGTON (NEXSTAR) — Americans face a hefty price tag for diabetes and weight-loss drugs. “The people of the United States ...

Swiftly achieving glycemic control after a diagnosis of gestational diabetes can bring the baby's risk obesity in childhood down to a level similar to that of children whose mothers did not have ...

Application error: a client-side exception has occurred (see the browser console for more information).

To address this, Dr Snell-Bergeon and colleagues assessed the effectiveness of the two drugs in T1D patients at a diabetes clinic in the US. The retrospective study involved reviewing the medical ...